IBDEI056 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2166,1,5,0)
 ;;=5^RENAL DIALYSIS STATUS
 ;;^UTILITY(U,$J,358.3,2166,2)
 ;;=^336792
 ;;^UTILITY(U,$J,358.3,2167,0)
 ;;=V45.00^^21^200^16
 ;;^UTILITY(U,$J,358.3,2167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2167,1,4,0)
 ;;=4^V45.00
 ;;^UTILITY(U,$J,358.3,2167,1,5,0)
 ;;=5^UNSP CARDIAC DEV IN SITU
 ;;^UTILITY(U,$J,358.3,2167,2)
 ;;=^295458
 ;;^UTILITY(U,$J,358.3,2168,0)
 ;;=V45.2^^21^200^17
 ;;^UTILITY(U,$J,358.3,2168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2168,1,4,0)
 ;;=4^V45.2
 ;;^UTILITY(U,$J,358.3,2168,1,5,0)
 ;;=5^VENTRICULAR SHUNT STATUS
 ;;^UTILITY(U,$J,358.3,2168,2)
 ;;=^295460
 ;;^UTILITY(U,$J,358.3,2169,0)
 ;;=V66.7^^21^201^34
 ;;^UTILITY(U,$J,358.3,2169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2169,1,4,0)
 ;;=4^V66.7
 ;;^UTILITY(U,$J,358.3,2169,1,5,0)
 ;;=5^ENCOUNTER-PALLIATIVE CARE
 ;;^UTILITY(U,$J,358.3,2169,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,2170,0)
 ;;=V46.2^^21^202^5
 ;;^UTILITY(U,$J,358.3,2170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2170,1,4,0)
 ;;=4^V46.2
 ;;^UTILITY(U,$J,358.3,2170,1,5,0)
 ;;=5^SUPPLEMENTAL OXYGEN
 ;;^UTILITY(U,$J,358.3,2170,2)
 ;;=^328702
 ;;^UTILITY(U,$J,358.3,2171,0)
 ;;=V69.2^^21^203^3
 ;;^UTILITY(U,$J,358.3,2171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2171,1,4,0)
 ;;=4^V69.2
 ;;^UTILITY(U,$J,358.3,2171,1,5,0)
 ;;=5^HI-RISK SEXUAL BEHAVIOR
 ;;^UTILITY(U,$J,358.3,2171,2)
 ;;=^303474
 ;;^UTILITY(U,$J,358.3,2172,0)
 ;;=V69.3^^21^203^2
 ;;^UTILITY(U,$J,358.3,2172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2172,1,4,0)
 ;;=4^V69.3
 ;;^UTILITY(U,$J,358.3,2172,1,5,0)
 ;;=5^GAMBLING & BETTING
 ;;^UTILITY(U,$J,358.3,2172,2)
 ;;=^303475
 ;;^UTILITY(U,$J,358.3,2173,0)
 ;;=V69.8^^21^203^4
 ;;^UTILITY(U,$J,358.3,2173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2173,1,4,0)
 ;;=4^V69.8
 ;;^UTILITY(U,$J,358.3,2173,1,5,0)
 ;;=5^SELF-DAMAGING BEHAVIOR
 ;;^UTILITY(U,$J,358.3,2173,2)
 ;;=^303476
 ;;^UTILITY(U,$J,358.3,2174,0)
 ;;=V65.42^^21^203^1
 ;;^UTILITY(U,$J,358.3,2174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2174,1,4,0)
 ;;=4^V65.42
 ;;^UTILITY(U,$J,358.3,2174,1,5,0)
 ;;=5^COUNSEL-SUBS USE/ABUSE
 ;;^UTILITY(U,$J,358.3,2174,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,2175,0)
 ;;=V68.89^^21^204^1
 ;;^UTILITY(U,$J,358.3,2175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2175,1,4,0)
 ;;=4^V68.89
 ;;^UTILITY(U,$J,358.3,2175,1,5,0)
 ;;=5^ADMIN ENC-ADV DIREC/LTC
 ;;^UTILITY(U,$J,358.3,2175,2)
 ;;=^295588
 ;;^UTILITY(U,$J,358.3,2176,0)
 ;;=V01.1^^21^205^7
 ;;^UTILITY(U,$J,358.3,2176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2176,1,4,0)
 ;;=4^V01.1
 ;;^UTILITY(U,$J,358.3,2176,1,5,0)
 ;;=5^TUBERCULOSIS CONTACT
 ;;^UTILITY(U,$J,358.3,2176,2)
 ;;=^295158
 ;;^UTILITY(U,$J,358.3,2177,0)
 ;;=V01.3^^21^205^6
 ;;^UTILITY(U,$J,358.3,2177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2177,1,4,0)
 ;;=4^V01.3
 ;;^UTILITY(U,$J,358.3,2177,1,5,0)
 ;;=5^SMALLPOX CONTACT
 ;;^UTILITY(U,$J,358.3,2177,2)
 ;;=^295160
 ;;^UTILITY(U,$J,358.3,2178,0)
 ;;=V01.4^^21^205^5
 ;;^UTILITY(U,$J,358.3,2178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2178,1,4,0)
 ;;=4^V01.4
 ;;^UTILITY(U,$J,358.3,2178,1,5,0)
 ;;=5^RUBELLA CONTACT
 ;;^UTILITY(U,$J,358.3,2178,2)
 ;;=^295161
 ;;^UTILITY(U,$J,358.3,2179,0)
 ;;=V01.5^^21^205^4
 ;;^UTILITY(U,$J,358.3,2179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2179,1,4,0)
 ;;=4^V01.5
 ;;^UTILITY(U,$J,358.3,2179,1,5,0)
 ;;=5^RABIES CONTACT
 ;;^UTILITY(U,$J,358.3,2179,2)
 ;;=^295162
 ;;^UTILITY(U,$J,358.3,2180,0)
 ;;=V01.6^^21^205^8
 ;;^UTILITY(U,$J,358.3,2180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2180,1,4,0)
 ;;=4^V01.6
 ;;^UTILITY(U,$J,358.3,2180,1,5,0)
 ;;=5^VENEREAL DIS CONTACT
